News by topic

Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

TB treatment news

Show

From To
TB treatment
Co-administration of rifampicin and efavirenz does not reduce efavirenz concentrations or efficacy

Standard dosing of efavirenz, that was not adjusted for patient weight, resulted in therapeutic efavirenz concentrations and excellent virological outcomes in patients coinfected with TB and HIV

Published
24 July 2012
By
Lesley Odendal
TB treatment
Trial Signals Major Milestone in Hunt for New TB Drugs

A novel approach to discover the first new tuberculosis (TB) combination drug regimen cleared a major hurdle when Phase II clinical trial results found it could kill more than 99 percent of patients’ TB bacteria within two weeks and could be more effective than existing treatments. These results add to a growing body of evidence that the new regimen could reduce treatment by more than a year for some patients.

Published
24 July 2012
From
TB Alliance
TB treatment
UCSF/SFGH Researchers Call for Change in New FDA Recommendation on HIV and TB Drug Doses

In January, 2012, the U.S. Food and Drug Administration (FDA) issued new guidelines on dosing of an HIV medication used to treat people infected with both HIV and tuberculosis (TB). Now, a new analysis by the University of California, San Francisco (UCSF) and the San Francisco General Hospital and Trauma Center (SFGH) suggests this recommended dose adjustment may not be necessary, particularly in non-Caucasian populations.

Published
24 July 2012
From
USCF News Center
Drug-resistant TB
Janssen Research & Development Submits New Drug Application to FDA for Investigational Multi-Drug Resistant Tuberculosis Treatment Bedaquiline (TMC207)

Janssen Research & Development, LLC (Janssen) today announced it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) seeking accelerated approval for the use of the investigational drug bedaquiline (TMC207) as an oral treatment, to be used as part of combination therapy for pulmonary, multi-drug resistant tuberculosis (MDR-TB) in adults.

Published
02 July 2012
From
PR Newswire (press release)
Tuberculosis and HIV
Ministers endorse declaration set to pave the way to zero TB deaths among miners in Southern Africa

Ministers of Health and Labour from the 15 Southern African Development Community (SADC) countries have endorsed a declaration on tuberculosis (TB) in the mining sector that is designed to drive a regional response to the issue.

Published
14 May 2012
From
Stop TB Partnership
TB treatment
Anya Sarang and Tim Rhodes: “The last way” clinic: why tuberculosis remains an incurable disease in Russia

From patients’ accounts of Kamskaya Clinic, you would not think that tuberculosis is a curable disease: “Our hospital is called ‘the last way.’ People come here only to die.”

Published
12 April 2012
From
BMJ blogs
TB treatment
Low CD4 cell count and older age associated with increased risk of TB after starting HIV therapy

People with HIV reduce their overall risk of tuberculosis (TB) by starting antiretroviral therapy, an international team of investigators report in the online edition of Clinical Infectious

Published
11 April 2012
By
Michael Carter
TB diagnosis
A low CD4 cell count, weight and haemoglobin can identify which HIV-positive patients are more likely to have undiagnosed TB

Undiagnosed tuberculosis (TB) is common among patients receiving routine HIV care in South Africa, a study published in the online edition of the Journal of Acquired Immune Deficiency

Published
04 April 2012
By
Michael Carter
Tuberculosis and HIV
TB, HIV, mothers and children: time for action

This year’s World TB Day edition of HATIP focusses on the needs of pregnant women and children with TB.

Published
23 March 2012
From
HIV & AIDS treatment in practice
TB treatment
New TB Treatment Options on Horizon

After nearly 50 years, the drug development pipeline for new tuberculosis (TB) treatments is finally opening up again, according to infectious disease specialists.

Published
20 March 2012
From
MedPage Today
← Prev1...23456...9Next →

Filter by country